• Explore /
  • Poster
  • / Exploratory biomarker analyses from ECOG 4508: Three-arm randomized phase II study of carboplatin (C) and paclitaxel (P) in combination with cetuximab (CET), IMC-A12, or both for advanced non-small cell lung cancer (NSCLC) patients (pts).

Exploratory biomarker analyses from ECOG 4508: Three-arm randomized phase II study of carboplatin (C) and paclitaxel (P) in combination with cetuximab (CET), IMC-A12, or both for advanced non-small cell lung cancer (NSCLC) patients (pts).

Abstract Poster

Authors

Charu Aggarwal

Charu Aggarwal

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

Charu Aggarwal , Suzanne Eleanor Dahlberg , Nasser Hanna , Jill Kolesar , Fred R. Hirsch , Suresh S. Ramalingam , Joan H. Schiller

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCI-2011-01976

Citation

J Clin Oncol 31, 2013 (suppl; abstr 8106)

DOI

10.1200/jco.2013.31.15_suppl.8106

Abstract #

8106

Poster Bd #

40F

Abstract Disclosures

Similar Posters

First Author: Nasser H. Hanna

First Author: M. H. Brutsche

First Author: Akito Hata

First Author: Yuangyuan Zhao